Filing search / Inhibrx Biosciences, Inc. / "Charitable"

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

6:38am

credit (including credits of a foreign company under Section 902 of the Code), overall foreign loss, excess charitable contribution, general business

8-K

EX-2.2

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

(including credits of a foreign company under Section 902 of the Code), overall foreign loss, excess charitable contribution, general business credit

S-1

EX-10.4

m1ad0s7qao9r25 smkqb

3 Jun 19

IPO registration

4:17pm

S-1

EX-10.2

ofzdm psk

3 Jun 19

IPO registration

4:17pm

S-1

EX-10.11

eueif aytojrc5wciy

3 Jun 19

IPO registration

4:17pm

S-1

EX-10.3

oq6abqgqhe8 cpu

3 Jun 19

IPO registration

4:17pm

DRS/A

EX-10.11

2un8nx6 inspit

22 Feb 19

Draft registration statement (amended)

12:00am

DRS

EX-10.2

66ak4vjdm2prlba

7 Jan 19

Draft registration statement

12:00am